首页 | 本学科首页   官方微博 | 高级检索  
检索        

利用CRISPR/Cas9技术体内标记示踪小鼠内源性NPC1L1蛋白
引用本文:武晓静,陈玉霞,麻献华,章卫平,.利用CRISPR/Cas9技术体内标记示踪小鼠内源性NPC1L1蛋白[J].天津医科大学学报,2022,0(1).
作者姓名:武晓静  陈玉霞  麻献华  章卫平  
作者单位:(1.天津医科大学朱宪彝纪念医院,天津市内分泌研究所,国家卫健委激素与发育重点实验室,天津市代谢性疾病重点实验室,天津300134;2.海军军医大学基础医学院病理生理学教研室,上海 200433)
摘    要:目的:对小鼠内源性NPC1L1蛋白进行标记和示踪,为研究体内胆固醇的吸收机制提供新的技术手段。方法:利用CRISPR/Cas9基因组编辑技术,针对小鼠NPC1L1基因的3′末端非编码区,设计不同sgRNA,利用细胞内的荧光素酶法,检测分析其Cas9/sgRNA核酸酶活性,筛选出高活性的sgRNA序列,经体外转录制备sgRNA和Cas9 mRNA。PCR扩增基因打靶的两侧同源臂,与FLAG-EGFP的编码cDNA一起克隆至打靶载体。经酶切和测序鉴定正确的打靶载体DNA与sgRNA、Cas9 mRNA一起显微注射入小鼠受精卵,移植至假孕小鼠体内自然发育;通过基因组DNA 的PCR和Southern 印迹分析,筛选、鉴定重组正确且无随机插入的子代小鼠。制备小肠组织冰冻切片,荧光显微镜下观察NPC1L1-EGFP的表达分布。结果:成功构建了NPC1L1基因敲入打靶载体,筛选了高活性的sgRNA,利用CRISPR/Cas9技术获得了对内源性NPC1L1蛋白C端进行FLAG和EGFP双重标记的子代小鼠,荧光显微镜下观察到该融合蛋白分布于小肠绒毛上皮细胞的刷状缘,与NPC1L1的分布特征一致。结论:成功实现了对小鼠内源性NPC1L1蛋白进行体内标记,为研究NPC1L1囊泡转运和胆固醇吸收机制提供了有效手段。

关 键 词:NPC1L1  CRISPR/Cas9  胆固醇吸收  示踪  转基因小鼠  标签蛋白

Genetic labeling and tracing of mouse endogenous NPC1L1 protein by CRISPR/Cas9 technology in vivo
WU Xiao-jing,CHEN Yu-xia,MA Xian-hua,ZHANG Wei-ping,' target="_blank" rel="external">.Genetic labeling and tracing of mouse endogenous NPC1L1 protein by CRISPR/Cas9 technology in vivo[J].Journal of Tianjin Medical University,2022,0(1).
Authors:WU Xiao-jing  CHEN Yu-xia  MA Xian-hua  ZHANG Wei-ping  " target="_blank">' target="_blank" rel="external">
Institution:(1.NHC Key Laboratory of Hormones and Development,Tianjin Key Laboratory of Metabolic Diseases,Chu Hsien-I Memorial Hospital, Tianjin Institute of Endocrinology,Tianjin Medical University,Tianjin 300134,China; 2.Department of Pathophysiology,College of Basic Medical Science,Navy Medical University,Shanghai 200433,China)
Abstract:Objective: To label and trace endogenous NPC1L1 protein in mouse model,providing a new tool for studying the absorption mechanisms of cholesterol in vivo. Methods:Using CRISPR/Cas9 genomic editing technology,different sgRNAs were designed according to the 3′ untranslated region of mouse NPC1L1 gene. The activity of Cas9/sgRNA nuclease was analyzed in cellular luciferase detection system,and the sgRNA sequence with high activity was screened out.The sgRNA and Cas9 mRNA were transcribed in vitro. The two homologous arms of the target gene were amplified by PCR and cloned into the target vector together with the cDNA encoding FLAG-EGFP. The correct targeting vector identified by restriction enzyme digestion and sequencing,along with sgRNA and cas9 mRNA were microinjected into fertilized eggs and then transplanted into pseudopregnant mice for natural development. The offspring mice with correct recombination and no random insertion were verified by PCR and Southern blotting analysis of genomic DNA. The expression of NPC1L1-FLAG-EGFP fusion protein was observed under fluorescence microscope using jejunal cryosections. Results: The FLAG-EGFP knock-in targeting vector of NPC1L1 gene was successfully constructed. The highly active sgRNA was determined,and the offspring mice with FLAG and EGFP dual-tags on the C-terminal of endogenous NPC1L1 protein were finally obtained by CRISPR/cas9 technology. The localization of the fusion protein along the brush border of villous epithelial cells in the small intestine was observed under fluorescence microscope,which was consistent with the distribution characteristics of NPC1L1. Conclusion: The successfully constructed mouse model with endogenous NPC1L1 protein labeling of dual-tags,FLAG and EGFP provides an effective tool to study the mechanism of vesicle transport and cholesterol absorption of NPC1L1 in vivo.
Keywords:NPC1L1  CRISPR/Cas9  cholesterol absorption  tracing  transgenic mice  tag protein
点击此处可从《天津医科大学学报》浏览原始摘要信息
点击此处可从《天津医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号